© Pint of Science, 2024. All rights reserved.
In this event we will explore the neurological consequences of different types of disease. Gwen Fernandes, Miranda Montano and Melody Bishop will speak about their research on how the (unfortunately) now very common Covid-19 can affect the brain. On the other end of the spectrum, Soledad Barez-Lopez will share her findings on the effects of a much rarer, but no less critical, condition which affects how the thyroid communicates with the brain.
When the thyroid can't speak to the brain
Dr Soledad Barez-Lopez
(Research Associate)
Do you know that 1 in 17 people will be affected by a rare disease at some point in their lives? However, because each rare disease affects fewer than 1 in 2,000 people, the diagnosis and treatments for this condition can be really challenging.
In this session Soledad will walk us through the science of discovering, understanding and developing therapeutic strategies to address rare diseases, in this case, through the Allan-Herndon-Dudley Syndrome.
In this session Soledad will walk us through the science of discovering, understanding and developing therapeutic strategies to address rare diseases, in this case, through the Allan-Herndon-Dudley Syndrome.
Minding Long COVID: the long-term neurological effects of COVID-19
Dr Gwen Fernandes
(Programme Manager)
Melody Bishop
(Information Officer)
Miranda Montano
(Public Health Data Assistance)
COVID19 abruptly impacted our lives in 2020 and since then we have continuously adapted to these new circumstances. In this session Gwen will walk us through COVID19-related research, in particular on the possible long-term effects of COVID on the brain including cognitive impairments, brain fog and memory loss.
Map data © OpenStreetMap contributors.